3.
Mosier, MJ, Pham, TN. American Burn Association practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res
2009;30:910–928.
4.
Weber, DJ, Sickbert-Bennett, EE, Brown, V, Rutala, WA. Completeness of surveillance data reported by the National Healthcare Safety Network: An analysis of healthcare-associated infections ascertained in a tertiary care hospital, 2010. Infect Control Hosp Epidemiol
2012;33:94–96.
5.
CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Informational Supplement. CLSI documents M100-S18 through M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2008–2012.
7.
Dudeck, MA, Weiner, LM, Allen-Bridson, K, Malpiedi, PJ, Peterson, KD, Pollack, DA, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device associated module. Am J Infect Control
2013;41:1148–1166.
8.
Lipovy, B, Rihova, H, Gregorova, N, Hanslianova, M, Zaloudikova, Z, Kaloudova, Y, et al. Epidemiology of ventilator-associated tracheobronchitis and ventilator-associated pneumonia in patients with inhalation injury at the burn centre in Brno (Czech Republic). Ann Burns Fire Disasters
2011;24:120–125.
9.
Brusselaers, N, Logie, D, Vogelaers, D, Monstrey, S, Blot, S. Burns, inhalation injury and ventilator-associated pneumonia: value of routine surveillance cultures. Burns
2012;38:364–370.
10.
Sievert, DM, Ricks, P, Edwards, JR, Schneider, A, Patel, J, Srinivasan, A. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol
2013;34:1–14.
